West Clinic Cancer Center is holding a ribbon cutting ceremony and reception to celebrate an advancement in lab technology and a partnership with Roche Tissue Diagnostics. The pathology laboratory has enhanced patient care by adding the Ventana Benchmark Ultra Automated Advanced Staining System to perform immunohistochemical/in situ-hybridization testing. This technology, from Roche Diagnostics, will provide advanced assay testing to pathologists resulting in faster diagnoses for the patients of West Cancer Center.
today announced the launch of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for the detection of the HER2 biomarker in breast and gastric cancer. HER2 - human epidermal growth factor receptor 2 - is an important biomarker found in breast and gastric cancers.4 Its detection and inhibition can help to more effectively manage these aggressive cancers.